For the Inventor, By the Inventor

Enter assignee name

Palo Alto, CA, United States of America

Telik, Inc.

USPTO Granted Patents = 37

% Expired Patents = 75.7

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 132

Loading Chart...

Loading Chart...

78 inventors (with patents filed for the assignee):

Steven R Schow (15 out of 29 patents)

Hugo O Villar (12 out of 21 patents)

Louise Robinson (11 out of 14 patents)

4. Robert T Lum (9 out of 25 patents)

5. Edgardo Laborde (7 out of 14 patents)

6. Wayne R Spevak (6 out of 12 patents)

7. Michael R Kozlowski (6 out of 15 patents)

8. Songyuan Shi (5 out of 35 patents)

9. Lawrence M Kauvar (5 out of 84 patents)

10. Wenli Ma (5 out of 5 patents)

11. Fanying Meng (5 out of 9 patents)

12. Brian T Peterson (5 out of 8 patents)

13. Yukiharu Matsumoto (5 out of 14 patents)

14. Prasad V V S V Manchem (5 out of 5 patents)

15. Kouji Matsushima (4 out of 39 patents)

Core Competencies:

Ezatiostat

Canfosfamide

Kinase Inhibitors

Insulin Receptor Agonists

Glucose Uptake Enhancers

MCP-1 Antagonists

Antitumor Agents

Therapeutic Compositions

Phosphorodiamidates

Benzimidazoles

Apoptosis Stimulators

Immunomodulators

37 patents: Sort by Forward Citations

1. 8841476 - Preparation of crystalline ezatiostat hydrochloride ansolvate form D (2014-09-23),

2. 8759303 - Compositions and methods for treating myelodysplastic syndrome (2014-06-24),

3. 8716521 - Formulations of canfosfamide and their preparation (2014-05-06),

4. 8481781 - Formulations of canfosfamide and their preparation (2013-07-09),

5. 8410163 - Substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carbonitriles and substituted 4-amino-5-benzoyl-2-(phenylamino)thiophene-3-carboxamides as tubulin polymerization inhibitors (2013-04-02),

6. 8361971 - Tablet formulation of ezatiostat (2013-01-29),

7. 8334266 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-12-18),

8. 8324426 - Formulations of canfosfamide and their preparation (2012-12-04),

9. 8207121 - Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound (2012-06-26),

10. 8198247 - Process for and intermediates in the preparation of canfosfamide and its salts (2012-06-12),

11. 8129396 - 2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors (2012-03-06),

12. 8093231 - Sulfonylethyl phosphorodiamidates (2012-01-10),

13. 7872134 - 2-{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidates (2011-01-18),

14. 7655799 - 2{[2-(substituted amino)ethyl]sulfonyl}ethyl N,N,N',N'-tetrakis(2-chloroethyl)phosphorodiamidates (2010-02-02),

15. 7297696 - Antagonists of MCP-1 function and methods of use thereof (2007-11-20),

Company Overview

Telik, Inc. is a biotechnology company based in Palo Alto, California, specializing in the discovery and development of innovative therapeutics for cancer and other serious diseases. The company focuses on harnessing its proprietary drug discovery platform to identify and develop small molecule drugs that target specific biological pathways. With a commitment to advancing precision medicine, Telik aims to improve patient outcomes through targeted therapies that address unmet medical needs.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

37 Patents

#53 in Palo Alto, CA

#2,187 in California

#9,251 in US

#18,260 in the World

Palo Alto, CA, United States of America

Telik, Inc.

Forward Citations = 132

78 inventors:

Steven R Schow (15 out of 29 patents)

Hugo O Villar (12 out of 21 patents)

Louise Robinson (11 out of 14 patents)

4. Robert T Lum (9 out of 25 patents)

5. Edgardo Laborde (7 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Telik, Inc.. Retrieved from https://idiyas.com/company/telik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…